Frederick W. Driscoll
Insider Reports History
- Location
- Madison, WI
- Signature
- /s/ Frederick W. Driscoll
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Frederick W. Driscoll:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MEI Pharma, Inc. | Director | Common Stock | 1,875 | $4,106 | $2.19 | 15 Jul 2025 | Direct |
| Renovacor, Inc. | Chief Financial Officer | Option | 155,325 | 28 Mar 2022 | Direct | ||
| Cellectar Biosciences, Inc. | Director | Stock option (right to buy) | 60,000 | 14 Feb 2025 | Direct | ||
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 55,000 | 14 Nov 2025 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24,400 | 02 Jan 2025 | Direct | ||
| Flexion Therapeutics Inc | Chief Financial Officer | Common Stock | 0 | $8.50 | 19 Nov 2021 | Direct | |
| Flexion Therapeutics Inc | Chief Financial Officer | Stock option (right to buy) | 0 | 19 Nov 2021 | Direct |